Johnson &Amp; Johnson (JNJ) — 8-K Filings

8-K Filings (19)

• 8-K Filing — Apr 14, 2026
• J&J Reports Financials, Details Debt Issuances — Oct 14, 2025 Risk: low
  Johnson & Johnson filed an 8-K on October 14, 2025, reporting on its financial condition and other events. The filing details various debt issuances, including
• J&J Board Changes and Executive Compensation Details — Sep 9, 2025 Risk: low
  Johnson & Johnson announced on September 8, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the departure
• J&J Files 8-K on Financials and Debt Offerings — Jul 16, 2025 Risk: low
  Johnson & Johnson filed an 8-K on July 16, 2025, reporting on its results of operations and financial condition. The filing includes various exhibits related to
• J&J Reports Director Changes and Debt Issuances — Jun 10, 2025 Risk: low
  Johnson & Johnson filed an 8-K on June 10, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory a
• J&J Files 8-K: Director Changes, Officer Comp, Shareholder Votes — Apr 30, 2025 Risk: low
  Johnson & Johnson filed an 8-K on April 30, 2025, reporting on the departure of directors, election of new directors, and compensatory arrangements for officers
• J&J Files 8-K Detailing Financials and Notes — Apr 15, 2025 Risk: low
  Johnson & Johnson filed an 8-K on April 15, 2025, reporting on its Results of Operations and Financial Condition, as well as other events and financial statemen
• J&J Files 8-K Detailing Debt Maturities — Apr 3, 2025 Risk: low
  Johnson & Johnson filed an 8-K on April 3, 2025, reporting on its financial statements and exhibits as of March 31, 2025. The filing details various notes with
• J&J Files 8-K on Multiple Debt Offerings — Feb 26, 2025 Risk: low
  On February 26, 2025, Johnson & Johnson filed an 8-K report detailing various debt issuances. These include $1.150 billion in notes due November 2028, $3.20 bil
• J&J Files 8-K on Debt Issuances — Feb 20, 2025 Risk: low
  On February 20, 2025, Johnson & Johnson filed an 8-K report detailing various debt issuances. These include notes due in November 2028, November 2032, 2035, Nov
• Johnson & Johnson Files 8-K with Financial Updates — Oct 15, 2024 Risk: low
  On October 15, 2024, Johnson & Johnson filed an 8-K report detailing financial information. The filing includes details on various notes due in different years,
• J&J Files 8-K on Debt Issuances — Sep 20, 2024 Risk: low
  On September 20, 2024, Johnson & Johnson filed an 8-K report detailing various debt issuances. These include notes due in 2024, 2028, 2032, 2035, 2036, and 2044
• J&J Board Changes and Officer Compensation Updates — Sep 10, 2024 Risk: low
  On September 10, 2024, Johnson & Johnson filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the filing an
• J&J Executive Shuffle: New CFO, Medical Devices Chair Departs — Aug 26, 2024 Risk: medium
  Johnson & Johnson announced on August 26, 2024, changes in its executive leadership, including the appointment of Thong Q. Nguyen as Executive Vice President, C
• J&J Files 8-K on Financials and Debt — Jul 17, 2024 Risk: low
  On July 17, 2024, Johnson & Johnson filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various
• J&J Issues $5B in Notes — May 20, 2024 Risk: low
  On May 20, 2024, Johnson & Johnson filed an 8-K report detailing the issuance of $5.0 billion aggregate principal amount of senior unsecured notes. The notes ar
• J&J Prices $15B in Senior Notes — May 17, 2024 Risk: low
  On May 17, 2024, Johnson & Johnson filed an 8-K report detailing the issuance of new debt. The company announced the pricing of $15 billion aggregate principal
• J&J Issues New Debt, Files Financials — Apr 29, 2024 Risk: low
  On April 25, 2024, Johnson & Johnson filed an 8-K report detailing the issuance of new debt securities. This includes $5.50 billion in notes due in 2024, $1.65
• J&J Files 8-K on Operations & Financial Condition, Details Notes Due — Jan 23, 2024
  Johnson & Johnson (JNJ) filed an 8-K on January 23, 2024, to report its results of operations and financial condition. The filing specifically mentions several

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX